Scholarlink

Background <p>The impact of switching to e-cigarettes in smokers after a chronic obstructive pulmonary disease (COPD) diagnosis on long-term health outcomes has not been widely evaluated.</p> Methods <p>This nationwide cohort included 23,262 adults aged 40–80 years who were current smokers at the time of COPD diagnosis between 2016 and 2023. Based on follow-up health screening data, patients were categorized as continued smokers, quitters, or e-cigarette users (including dual users). The outcomes included lung cancer, COPD exacerbations, major adverse cardiac and cerebrovascular events (MACCE), and all-cause mortality. Adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) were estimated using Cox proportional hazards model.</p> Results <p>Among 23,262 patients with COPD, 14,899 (64.0%) continued smoking, 7,047 (30.3%) quit, and 1,316 (5.7%) switched to e-cigarettes. During follow-up, quitters had significantly lower risks of lung cancer (adjusted HR [aHR], 0.85; 95% CI, 0.72–0.99), COPD exacerbations (aHR, 0.90; 95% CI, 0.84–0.97), MACCE (aHR, 0.85; 95% CI, 0.79–0.93), and all-cause mortality (aHR, 0.90; 95% CI, 0.82–0.99) compared with continued smokers. Switching to e-cigarettes was not associated with a lower risk of lung cancer (aHR, 0.94; 95% CI, 0.65–1.37) or COPD exacerbations (aHR, 0.98; 95% CI, 0.84–1.14) but was associated with a reduced risk of MACCE (aHR, 0.80; 95% CI, 0.66–0.97).</p> Conclusions <p>Complete smoking cessation was associated with lower risks of lung cancer, COPD exacerbations, MACCE, and all-cause mortality. In contrast, switching to e-cigarettes was associated with a reduced risk of MACCE but did not provide comparable respiratory benefits.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

E-cigarette switching in COPD: reduced cardiovascular events without improvement in respiratory outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月12日

查看全文
  • Taeyun Kim,
  • Hyunsoo Kim,
  • Sun Hye Shin,
  • Seoyoung Choi,
  • Eunji Jeong,
  • Chaiyoung Lee,
  • Danbee Kang,
  • Hye Yun Park

摘要

Background

The impact of switching to e-cigarettes in smokers after a chronic obstructive pulmonary disease (COPD) diagnosis on long-term health outcomes has not been widely evaluated.

Methods

This nationwide cohort included 23,262 adults aged 40–80 years who were current smokers at the time of COPD diagnosis between 2016 and 2023. Based on follow-up health screening data, patients were categorized as continued smokers, quitters, or e-cigarette users (including dual users). The outcomes included lung cancer, COPD exacerbations, major adverse cardiac and cerebrovascular events (MACCE), and all-cause mortality. Adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs) were estimated using Cox proportional hazards model.

Results

Among 23,262 patients with COPD, 14,899 (64.0%) continued smoking, 7,047 (30.3%) quit, and 1,316 (5.7%) switched to e-cigarettes. During follow-up, quitters had significantly lower risks of lung cancer (adjusted HR [aHR], 0.85; 95% CI, 0.72–0.99), COPD exacerbations (aHR, 0.90; 95% CI, 0.84–0.97), MACCE (aHR, 0.85; 95% CI, 0.79–0.93), and all-cause mortality (aHR, 0.90; 95% CI, 0.82–0.99) compared with continued smokers. Switching to e-cigarettes was not associated with a lower risk of lung cancer (aHR, 0.94; 95% CI, 0.65–1.37) or COPD exacerbations (aHR, 0.98; 95% CI, 0.84–1.14) but was associated with a reduced risk of MACCE (aHR, 0.80; 95% CI, 0.66–0.97).

Conclusions

Complete smoking cessation was associated with lower risks of lung cancer, COPD exacerbations, MACCE, and all-cause mortality. In contrast, switching to e-cigarettes was associated with a reduced risk of MACCE but did not provide comparable respiratory benefits.